Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117954

c-KIT expression enhances the leukemogenic potential of 32D cells.

Q Hu, M Trevisan, Y Xu, W Dong, S A Berger, S D Lyman, and M D Minden

Department of Medical Biophysics and Medicine, University of Toronto, Ontario, Canada.

Find articles by Hu, Q. in: JCI | PubMed | Google Scholar

Department of Medical Biophysics and Medicine, University of Toronto, Ontario, Canada.

Find articles by Trevisan, M. in: JCI | PubMed | Google Scholar

Department of Medical Biophysics and Medicine, University of Toronto, Ontario, Canada.

Find articles by Xu, Y. in: JCI | PubMed | Google Scholar

Department of Medical Biophysics and Medicine, University of Toronto, Ontario, Canada.

Find articles by Dong, W. in: JCI | PubMed | Google Scholar

Department of Medical Biophysics and Medicine, University of Toronto, Ontario, Canada.

Find articles by Berger, S. in: JCI | PubMed | Google Scholar

Department of Medical Biophysics and Medicine, University of Toronto, Ontario, Canada.

Find articles by Lyman, S. in: JCI | PubMed | Google Scholar

Department of Medical Biophysics and Medicine, University of Toronto, Ontario, Canada.

Find articles by Minden, M. in: JCI | PubMed | Google Scholar

Published June 1, 1995 - More info

Published in Volume 95, Issue 6 on June 1, 1995
J Clin Invest. 1995;95(6):2530–2538. https://doi.org/10.1172/JCI117954.
© 1995 The American Society for Clinical Investigation
Published June 1, 1995 - Version history
View PDF
Abstract

The growth of human leukemic cells in culture and in vivo is dependent upon the presence of hematopoietic growth factors. Most populations of human leukemic acute myeloblastic leukemia (AML) cells express c-Kit on their surface and respond to Kit ligand (KL) in culture. To determine if this interaction was of potential significance in vivo we used a mouse model system. 32D cells, a murine IL-3-dependent myeloid cell line, were rendered KL responsive by transfection of the murine c-Kit. After injection of 32D or 32D-Kit cells into syngeneic hosts, animals bearing 32D-Kit cells, but not 32D cells, became moribund and were killed. These animals had circulating leukemic blast cells, infiltration of bone marrow, spleen, brain, liver, lung, and kidney. Cells recovered from some of the animals continued to be dependent upon IL-3 or KL for growth while in other cases the cells were factor independent. This model illustrates that the constitutive expression of c-Kit enhances the leukemic potential of 32D cells. The model will be useful for studying the progression of leukemia in vivo and testing whether interruption of the interaction of Kit and KL can affect the growth of leukemic cells.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2530
page 2530
icon of scanned page 2531
page 2531
icon of scanned page 2532
page 2532
icon of scanned page 2533
page 2533
icon of scanned page 2534
page 2534
icon of scanned page 2535
page 2535
icon of scanned page 2536
page 2536
icon of scanned page 2537
page 2537
icon of scanned page 2538
page 2538
Version history
  • Version 1 (June 1, 1995): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts